Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local fibrinogen for postoperative bleeding in open prostatectomy
IRCT20170421033564N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of Fibrinogen human in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Bleeding during and after prostatectomy and Use of blood products. Started Apr 2018; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20170421033564N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170421033564N1.